Evidence map›Paper›PMID 18046883›Full record

Trial reportClinical interventions in aging2006

Are hypertensive elderly patients treated differently?

Amy D G Huebschmann, Caroline Bublitz, Robert J Anderson

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical interventions in aging, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Amy D G HuebschmannUniversity of Colorado-Denver Health Sciences Center (UCDHSC), Department of Internal Medicine, Division of General Internal Medicine, Denver, CO 80045, USA. Amy.Huebschmann@uchsc.edu
Caroline Bublitz
Robert J Anderson
University of Colorado Denver · USUniversity of Colorado Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectives1. To determine if there are differences in the classes of antihypertensive agents prescribed for the elderly population as compared with younger patients. 2. To compare patterns of antihypertensive therapy with established national guidelines.

designNational Ambulatory Medical Care Survey (NAMCS) database analysis from 1995-2000.

settingMultiple outpatient clinic settings in the US.

participantsPrimary care and sub-specialty physicians and their patients. MEASUREMENTS: 332510280 outpatient visits with an ICD-9 code corresponding to a diagnosis of hypertension were analyzed. The class(es) of antihypertensive medications that patients were already taking and/or those added in that visit were noted. Demographics of the patients were also analyzed.

resultsThere was a statistically significant association between the prescription of diuretics, calcium-channel blockers (CCBs), alpha-1-blockers (A1Bs), alpha-2 agonists (A2Ags) and age > or = 65 years.

conclusionPatients aged 65 and over were prescribed different types of medications than those under age 65. Increased usage of diuretics and CCBs were in accordance with evidence-based guidelines for this group. A1Bs were likely used more due to co-morbid benign prostatic hyperplasia (BPH), but this is not certain. The increased prescription of A2Ags likely reflects long-term usage of these medications, which nonetheless may be hazardous due to their potential for causing increased cognitive dysfunction in the aged.

Indexed as

Practice Patterns, Physicians'AgedAged, 80 and overAntihypertensive AgentsDrug PrescriptionsFemaleHealth Care SurveysHumansHypertensionMaleUnited StatesAntihypertensive Agents

Identifiers

PMID18046883
PMCPMC2695181
OpenAlexW2044917234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.